• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒林酸与钙和维生素D对家族性腺瘤性息肉病患者上消化道息肉的前瞻性随机研究

Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.

作者信息

Seow-Choen F, Vijayan V, Keng V

机构信息

Department of Colorectal Surgery, Singapore General Hospital, Singapore.

出版信息

Br J Surg. 1996 Dec;83(12):1763-6. doi: 10.1002/bjs.1800831232.

DOI:10.1002/bjs.1800831232
PMID:9038563
Abstract

Eighteen patients with familial adenomatous polyposis (FAP) who had previously undergone colectomy but had upper gastrointestinal polyps were studied in a double-blind randomized crossover trial comparing sulindac with calcium and calciferol. Sulindac produced a reduction in the crypt proliferation index in the gastric epithelium of patients but did not significantly affect duodenal mucosa. Calcium with calciferol did not have any effects on crypt proliferation index in patients with FAP.

摘要

18例家族性腺瘤性息肉病(FAP)患者曾接受过结肠切除术,但存在上消化道息肉,在一项双盲随机交叉试验中对舒林酸与钙及骨化醇进行了比较研究。舒林酸使患者胃上皮隐窝增殖指数降低,但对十二指肠黏膜无显著影响。钙与骨化醇对FAP患者的隐窝增殖指数没有任何影响。

相似文献

1
Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.舒林酸与钙和维生素D对家族性腺瘤性息肉病患者上消化道息肉的前瞻性随机研究
Br J Surg. 1996 Dec;83(12):1763-6. doi: 10.1002/bjs.1800831232.
2
Effect of sulindac on small polyps in familial adenomatous polyposis.舒林酸对家族性腺瘤性息肉病中小息肉的影响。
Lancet. 1995 Apr 1;345(8953):855-6.
3
Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.舒林酸对家族性腺瘤性息肉病患者十二指肠和直肠息肉及细胞增殖影响的随机对照试验
Br J Surg. 1993 Dec;80(12):1618-9. doi: 10.1002/bjs.1800801244.
4
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.依氟鸟氨酸(CPP-1X)/舒林酸联合疗法与单药疗法治疗家族性腺瘤性息肉病(FAP)患者的疗效和安全性:一项随机、双盲、III期试验的设计与原理
BMC Gastroenterol. 2016 Aug 2;16(1):87. doi: 10.1186/s12876-016-0494-4.
5
Sulindac for periampullary polyps in FAP patients.舒林酸用于家族性腺瘤性息肉病(FAP)患者的壶腹周围息肉。
Int J Colorectal Dis. 1997;12(1):14-8. doi: 10.1007/s003840050071.
6
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.舒林酸治疗家族性腺瘤性息肉病患者的结肠和直肠腺瘤
N Engl J Med. 1993 May 6;328(18):1313-6. doi: 10.1056/NEJM199305063281805.
7
Gastroduodenal polyps in familial adenomatous polyposis.
Surg Endosc. 1996 Nov;10(11):1118-9. doi: 10.1007/s004649900258.
8
Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.影响家族性腺瘤性息肉病患者胃和十二指肠表型外显率的变量。
BMC Gastroenterol. 2018 Jul 16;18(1):115. doi: 10.1186/s12876-018-0841-8.
9
Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.舒林酸治疗后家族性腺瘤性息肉病患者的直肠增生和息肉发生情况。
Gastroenterology. 1994 Feb;106(2):362-6. doi: 10.1016/0016-5085(94)90593-2.
10
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.舒林酸与厄洛替尼对比安慰剂对家族性腺瘤性息肉病十二指肠肿瘤的影响:一项随机临床试验
JAMA. 2016;315(12):1266-75. doi: 10.1001/jama.2016.2522.

引用本文的文献

1
Which Drugs are More Effective in Preventing Familial Adenomatous Polyposis Progression based on Network Meta-analysis?基于网络荟萃分析,哪些药物在预防家族性腺瘤性息肉病进展方面更有效?
Curr Pharm Des. 2024;30(20):1548-1563. doi: 10.2174/0113816128289465240422074745.
2
Chemoprevention in hereditary digestive neoplasia: A comprehensive review.遗传性消化系肿瘤的化学预防:综述
Therap Adv Gastroenterol. 2023 Dec 1;16:17562848231215585. doi: 10.1177/17562848231215585. eCollection 2023.
3
Endoscopic management of non-ampullary duodenal adenomas.
非壶腹十二指肠腺瘤的内镜治疗
Endosc Int Open. 2022 Jan 14;10(1):E96-E108. doi: 10.1055/a-1723-2847. eCollection 2022 Jan.
4
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.肿瘤学中的药物再利用:结直肠癌的化合物、途径、表型和计算方法。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):434-454. doi: 10.1016/j.bbcan.2019.04.005. Epub 2019 Apr 26.
5
Chemoprevention of familial adenomatous polyposis.家族性腺瘤性息肉病的化学预防
Fam Cancer. 2016 Jul;15(3):467-75. doi: 10.1007/s10689-016-9901-9.
6
Chemoprevention in familial adenomatous polyposis.家族性腺瘤性息肉病的化学预防。
Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):607-22. doi: 10.1016/j.bpg.2011.08.002.
7
Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis.家族性腺瘤性息肉病中十二指肠和壶腹腺瘤病的胰十二指肠切除术。
HPB (Oxford). 2011 May;13(5):342-9. doi: 10.1111/j.1477-2574.2011.00292.x. Epub 2011 Mar 10.
8
Functional outcome after restorative proctocolectomy in pigs: comparing a novel transverse ileal pouch to the J-pouch and straight ileoanal anastomosis.猪行恢复性直肠结肠切除术后的功能结局:新型横结肠回肠贮袋与J形贮袋及直回肠肛管吻合术的比较
J Gastrointest Surg. 2009 Feb;13(2):261-8. doi: 10.1007/s11605-008-0682-9. Epub 2008 Sep 13.
9
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.家族性腺瘤性息肉病中上消化道疾病的监测与管理
Fam Cancer. 2006;5(3):263-73. doi: 10.1007/s10689-005-5668-0.
10
Prevention and management of duodenal polyps in familial adenomatous polyposis.家族性腺瘤性息肉病中十二指肠息肉的预防与管理
Gut. 2005 Jul;54(7):1034-43. doi: 10.1136/gut.2004.053843.